// App-Quantinova.ai

888 : A unique allogeneic cell therapy platform for the treatment of a broad range of malignancies

Researchers

Presenter

  • Istvan Kovacs

Principal Investigators

  • Andre Simoes

  • Tim Recaldin

  • Elizabeth Reynolds

  • Katharina Bergerhoff

  • Mihil Patel

  • Rebecca Alade

  • Victoria Hillerdal

  • Andrew Hutton

  • Daniel Fowler

  • Joanna Kawalkowska

  • Kalle Soderstrom

  • Valentino Parravicini

  • Michael Koslowski

  • Oliver Nussbaumer

  • Alice Brown

Medical Centers

  • -GammaDelta Therapeutics, -, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Lymphomas

  • Solid malignancies

  • Graft-versus-host disease

Biomarkers

  • Cluster of Differentiation 19

  • Glomeruloid microvascular proliferation

  • Interferon-gamma

  • Natural killer group 2D

Drug/Treatment

  • Interferon Gamma

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved